Treatment of diseases mediated by the nitric oxide/cGMP/protein

Details Treatment of diseases mediated by the nitric oxide/cGMP/protein Treatment of diseases mediated by the nitric oxide/cGMP/protein

1997-09-18

1999-11-23

Reamer, James H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514724, 514739, A61K 31045

Patent

active

059901772

ABSTRACT:
Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.

REFERENCES:
patent: 5747532 (1998-05-01), Lai
Merck Index, 10th Edn, # 1708, 2696, 3744, 7756, 9522, 1983.

Affiliated with

Also associated with

Rating

Treatment of diseases mediated by the nitric oxide/cGMP/protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of diseases mediated by the nitric oxide/cGMP/protein , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diseases mediated by the nitric oxide/cGMP/protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1222639